Anuh Pharma has entered into a Memorandum of Understanding (MoU) with Invent Pharma, to acquire fixed assets of latter’s research and development laboratory situated in a leased premise in TTC Industrial Area, Navi Mumbai. The company is also mulling to intensify its own research and development activity with a view to enlarge its bulk drugs portfolio.
Anuh Pharma is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The company is part of the SK Group, which has evolved as a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1875.00 |
| Dr. Reddys Lab | 1283.90 |
| Cipla | 1336.45 |
| Zydus Lifesciences | 939.65 |
| Lupin | 2250.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: